Cost of Managing Actinic Keratosis Varies; Opportunity to Improve Value

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 1, 2017

Media Advisory: To contact corresponding study author Joslyn S. Kirby, M.D., M.S., M.Ed., email Matt Solovey at msolovey@pennstatehealth.psu.edu.

Related material: The editorial, “Helping Patients Decide on Treatment Options for Actinic Keratosis – Living in Cryo Nation,” by Jorge Roman, B.S., of the University of Texas Medical Branch, Galveston, and David J. Elpern, M.D., of The Skin Clinic, Williamstown, Mass., also is available on the For The Media website.

Related audio material: An author audio interview is available for preview on the For The Media website. The podcast will be live on the JAMA Dermatology website when the embargo lifts.

To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2016.4733

 

JAMA Dermatology

Actinic keratoses – or AK – are skin growths that most commonly appear on sun-exposed areas. These growths require regular management because a small proportion of them can progress to squamous cell skin cancer.

A new article and podcast published online by JAMA Dermatology examines geographic variability in health care usage and spending for the management of AK. Understanding geographic variation in AK spending is an opportunity to decrease waste or recoup excess spending, according to the report.

Joslyn S. Kirby, M.D., M.S., M.Ed., of the Penn State Milton S. Hershey Medical Center, Hershey, Pa., and coauthors, used data from a medical claims database for their study that examined geographic variation in health care costs and the association with patient-related and health-related factors.

To read the full study and preview the podcast, please visit the For The Media website.

(JAMA Dermatology. Published online March 1, 2017. doi:10.1001/jamadermatol.2016.4733; available pre-embargo at the For The Media website.)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

 

#  #  #

 

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.